Deforche K - Search Results

1

Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G.

Abecasis AB, Deforche K, Snoeck J, Bacheler LT, McKenna P, Carvalho AP, Gomes P, Camacho RJ, Vandamme AM. Abecasis AB, et al. Among authors: deforche k. AIDS. 2005 Nov 4;19(16):1799-806. doi: 10.1097/01.aids.0000188422.95162.b7. AIDS. 2005. PMID: 16227787

2

Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.

Snoeck J, Kantor R, Shafer RW, Van Laethem K, Deforche K, Carvalho AP, Wynhoven B, Soares MA, Cane P, Clarke J, Pillay C, Sirivichayakul S, Ariyoshi K, Holguin A, Rudich H, Rodrigues R, Bouzas MB, Brun-Vézinet F, Reid C, Cahn P, Brigido LF, Grossman Z, Soriano V, Sugiura W, Phanuphak P, Morris L, Weber J, Pillay D, Tanuri A, Harrigan RP, Camacho R, Schapiro JM, Katzenstein D, Vandamme AM. Snoeck J, et al. Among authors: deforche k. Antimicrob Agents Chemother. 2006 Feb;50(2):694-701. doi: 10.1128/AAC.50.2.694-701.2006. Antimicrob Agents Chemother. 2006. PMID: 16436728 Free PMC article.

3

Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG.

Abecasis AB, Deforche K, Bacheler LT, McKenna P, Carvalho AP, Gomes P, Vandamme AM, Camacho RJ. Abecasis AB, et al. Among authors: deforche k. Antivir Ther. 2006;11(5):581-9. Antivir Ther. 2006. PMID: 16964826

4

Bayesian network analyses of resistance pathways against efavirenz and nevirapine.

Deforche K, Camacho RJ, Grossman Z, Soares MA, Van Laethem K, Katzenstein DA, Harrigan PR, Kantor R, Shafer R, Vandamme AM; non-B Workgroup. Deforche K, et al. AIDS. 2008 Oct 18;22(16):2107-15. doi: 10.1097/QAD.0b013e32830fe940. AIDS. 2008. PMID: 18832874 Free PMC article.

5

The rise and fall of K65R in a Portuguese HIV-1 Drug Resistance database, despite continuously increasing use of tenofovir.

Theys K, Vercauteren J, Abecasis AB, Libin P, Deforche K, Vandamme AM, Camacho R. Theys K, et al. Among authors: deforche k. Infect Genet Evol. 2009 Jul;9(4):683-8. doi: 10.1016/j.meegid.2008.10.013. Epub 2008 Nov 6. Infect Genet Evol. 2009. PMID: 19038365

6

A genotypic assay for the amplification and sequencing of gag and protease from diverse human immunodeficiency virus type 1 group M subtypes.

Van Laethem K, Schrooten Y, Dedecker S, Van Heeswijck L, Deforche K, Van Wijngaerden E, Van Ranst M, Vandamme AM. Van Laethem K, et al. Among authors: deforche k. J Virol Methods. 2006 Mar;132(1-2):181-6. doi: 10.1016/j.jviromet.2005.10.008. Epub 2005 Nov 4. J Virol Methods. 2006. PMID: 16271771

7

Estimating the relative contribution of dNTP pool imbalance and APOBEC3G/3F editing to HIV evolution in vivo.

Deforche K, Camacho R, Laethem KV, Shapiro B, Moreau Y, Rambaut A, Vandamme AM, Lemey P. Deforche K, et al. J Comput Biol. 2007 Oct;14(8):1105-14. doi: 10.1089/cmb.2007.0073. J Comput Biol. 2007. PMID: 17985990 Free article.

8

The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal.

Vercauteren J, Deforche K, Theys K, Debruyne M, Duque LM, Peres S, Carvalho AP, Mansinho K, Vandamme AM, Camacho R. Vercauteren J, et al. Among authors: deforche k. Retrovirology. 2008 Feb 1;5:12. doi: 10.1186/1742-4690-5-12. Retrovirology. 2008. PMID: 18241328 Free PMC article.

9

Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.

Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Deforche K, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, Liesnard C, Moutschen M, Pierard D, Rens R, Schrooten Y, Vaira D, van den Heuvel A, van der Gucht B, van Ranst M, van Wijngaerden E, Vandercam B, Vekemans M, Verhofstede C, Clumeck N, Vandamme AM, van Laethem K. Vercauteren J, et al. Among authors: deforche k. AIDS Res Hum Retroviruses. 2008 Mar;24(3):355-62. doi: 10.1089/aid.2007.0212. AIDS Res Hum Retroviruses. 2008. PMID: 18327983

10

Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates.

Gonzalez LM, Santos AF, Abecasis AB, Van Laethem K, Soares EA, Deforche K, Tanuri A, Camacho R, Vandamme AM, Soares MA. Gonzalez LM, et al. Among authors: deforche k. J Antimicrob Chemother. 2008 Jun;61(6):1201-4. doi: 10.1093/jac/dkn099. Epub 2008 Mar 20. J Antimicrob Chemother. 2008. PMID: 18356151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page